Atelectasis caused by macrolide-resistant Mycoplasma pneumoniae pneumonia in an adult patient

Journal of Infection and Chemotherapy

Volumn 19, Issue 6, 2013, Pages 1161-1166

  Miyashita, Naoyuki ^a   Kawai, Yasuhiro ^a   Akaike, Hiroto ^a   Teranishi, Hideto ^a   Ouchi, Kazunobu ^a   Okimoto, Niro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atelectasis; Macrolide resistant; Mycoplasma pneumoniae; Radiographic finding

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GARENOXACIN; LEVOFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; RNA 23S; ROKITAMYCIN; TETRACYCLINE; TOSUFLOXACIN;

ACUTE NECROTIZING BRONCHITIS; ADULT; ANAMNESIS; ANTIBIOTIC THERAPY; ARTICLE; ATELECTASIS; BACTERIUM CULTURE; BRONCHITIS; BRONCHOSCOPY; BRONCHUS; BRONCHUS OBSTRUCTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; EDEMA; FEMALE; FEVER; GENERAL CONDITION IMPROVEMENT; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUNG INFILTRATE; MACROLIDE RESISTANT MYCOPLASMA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; PHYSICAL EXAMINATION; PNEUMONIA; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA 23S GENE; RNA GENE; SEROCONVERSION; SORE THROAT; SWELLING; THORAX RADIOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; PULMONARY ATELECTASIS;

EID: 84890855915     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0575-z     Document Type: Article

References (28)

1. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections. The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology 2006;11(suppl 3):79-133.
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17:697-728.
3. National Institute of Health. Infectious Disease Surveillance Center. Mycoplasma pneumoniae pneumonia. http://idsc.nih.go.jp/idwr/kanja/weeklygraph/ 18myco.html. Accessed 17 Dec 2012.
4. John SD, Ramanathan J, Swischuk LE. Spectrum of clinical and radiographic findings in pediatric Mycoplasma pneumonia. RadioGraphics. 2001;21:121-31.
5. Lee I, Kim TS, Yoon H-K. Mycoplasma pneumoniae pneumonia: CT features in 16 patients. Eur Radiol. 2006;16:719-25.
6. Vervolet LA, Camargos PAM, Soares DRF, de Oliveira GA, de Oliveira JN. Clinical, radiographic and hematological characteristics of Mycoplasma pneumoniae pneumonia. J Pediatr. 2010;86:480-7.
7. Tanaka N, Matsumoto T, Kuramitsu T, Nakai H, Ito K, Uchisako H, et al. High resolution CT findings in community-acquired pneumonia. J Comput Assist Tomogr. 1996;20:600-8.
8. Reittner P, Ward S, Heyneman L, Johkoh T, Muller NL. Pneumonia: high-resolution CT findings in 114 patients. Eur Radiol. 2003;13:515-21.
9. Okada F, Ando Y, Wakisaka M, Matsumoto S, Mori H. Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia. Comparison of clinical findings and CT findings. J Comput Assist Tomogr. 2005;29:626-32.
10. Nambu A, Saito A, Araki T, Ozawa K, Hiejima Y, Akao M, et al. Chlamydia pneumoniae: comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT. Radiology. 2006;238:330-8.
11. Nei T, Yamano Y, Sakai F, Kudoh S. Mycoplasma pneumoniae pneumonia: differential diagnosis by computerized tomography. Intern Med. 2007;46:1083-7.
12. Miyashita N, Sugiu T, Kawai K, Oda K, Yamaguchi T, Ouchi K, et al. Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing. BMC Med Imaging. 2009;9:7.
13. Ito I, Ishida T, Togashi K, Niimi A, Koyama H, Ishimori T, et al. Differentiation of bacterial and non-bacterial community-acquired pneumonia by thin-section computed tomography. Eur J Radiol. 2009;72:388-95.
14. Miyashita N, Kawai Y, Yamaguchi T, Ouchi K, Oka M, Atypical Pathogen Study Group. Clinical potential of diagnostic methods for the rapid diagnosis of Mycoplasma pneumoniae pneumonia in adults. Eur J Clin Microbiol Infect Dis. 2011;30:439-46.
15. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis. 2012;12:126.
16. Akaike H, Miyashita N, Kubo M, Kawai Y, Tanaka T, Ogita S, et al. In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates in pediatric patients: results from multicenter surveillance. Jpn J Infect Dis. 2012;65:535-8.
17. Muller NL, Miller RR. Disease of the bronchioles: CT and histopathologic findings. Radiology. 1995;176:243-8.
18. Worthy SA, Muller NL. Small airway diseases. Radiol Clin N Am. 1998;36:163-73.
19. Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med. 1986;110:34-41.
20. Jeffery P, Zhu J. Mucin-producing elements and inflammatory cells. Novartis Found Symp. 2002;248:51-68.
21. Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, et al. TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol. 2005;174:5713-9.
22. Leong MA, Nachajon R, Ruchelli E, Allen JL. Bronchiolitis obliterans due to Mycoplasma pneumonia. Pediatr Pulmonol. 1997;23:375-81.
23. Morozumi M, Takahashi T, Ubukata K. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia. J Infect Chemother. 2010;16:78-86.
24. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother. 2006;50:709-12.
25. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother. 2009;15:380-3.
26. Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Respirology. 2012;17:354-62.
27. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis. 2012;55:1642-9.
28. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, et al. Therapeutic efficacy of macrolides, minocycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients. Antimicrob Agents chemother (in press).